Role of Long Noncoding RNA Regulator of Reprogramming in Colon Cancer Progression via Epidermal Growth Factor Receptor Signaling
Background: Long intergenic noncoding RNA regulator of reprogramming (linc-ROR) is a novel long noncoding RNA that exhibits significant effects on cancer progression. This research presented that linc-ROR had a crucial part in promoting biological characteristics associated with worse prognosis in c...
Main Authors: | Ying Chen PhD, Li Yang BA, Dian Yin MM, Xiu Feng, Jing Jie Phd, DengFu Yao PhD, JianRong Chen PhD |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2022-08-01
|
Series: | Technology in Cancer Research & Treatment |
Online Access: | https://doi.org/10.1177/15330338221114707 |
Similar Items
-
Advances in the Treatment of Rare Epidermal Growth Factor Receptor Mutations in Advanced Nonsmall-Cell Lung Cancer
by: Limeng Yu MM, et al.
Published: (2023-04-01) -
Ex Vivo and In Vivo Noninvasive Imaging of Epidermal Growth Factor Receptor Inhibition on Colon Tumorigenesis Using Activatable Near-Infrared Fluorescent Probes
by: Shengli Ding PhD, et al.
Published: (2017-09-01) -
Long Noncoding RNAs: Emerging Biomarkers of Therapy Resistance and Tumor Progression
by: Ravindra P. Deshpande PhD
Published: (2023-01-01) -
Evidence for Monocyte Reprogramming in a Long-Term Postsepsis Study
by: Raquel Bragante Gritte, PhD, et al.
Published: (2022-08-01) -
Potential Efficacy of Shiunko for Anti-Epidermal Growth Factor Receptor (EGFR) Monoclonal Antibody-Induced Skin Fissure: A Single Institutional Case Series
by: Mashiro Okunaka PhD, et al.
Published: (2024-01-01)